Research and clinical care of adrenal diseases have improved significantly even in the past few years. Endocrine News speaks with a few notable experts in this space about these developments, gaps that are currently barriers to further ones, and how research informs the clinic and back again. When Gary D. Hammer, MD, PhD, professor of...
The Endocrine Society maintains a Government and Public Affairs Department that staffs the organization’s advocacy activities. This Spring the Society has worked on a variety of policy issues that affect our members. This includes: We have provided additional details on some of these topics below. If you are interested in learning more, please contact [email protected]...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Boehringer Ingelheim’s Novel Glucagon/GLP-1 Dual Agonist Survodutide Shows Promise in Phase 3 Trial On April 28, Boehringer Ingelheim announced positive topline results from the Phase III SYNCHRONIZE-1 trial, in which survodutide (BI 456906) met the co-primary endpoints using both the efficacy...
As my presidential term winds down, I look back with pride and admiration at the sheer amount of exemplary programming that the Society provides for its members each year. I’d like to recount some highlights from the past 12 months as we prepare to change leadership at ENDO 2026, June 13-16, in Chicago, Ill. One...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Sanofi’s Tzield Approved in the US to Delay Onset of Stage 3 Type 1 Diabetes in Young Children The U.S. Food and Drug Administration (FDA) has approved the supplemental biologic license application for Tzield (teplizumab-mzwv), expanding the indication from eight years...
Endocrine Society member Joseph T. Bass, MD, PhD, has been elected to the American Academy of Arts & Sciences (AAAS). Bass is the Charles F. Kettering Professor of Medicine at Northwestern University Feinberg School of Medicine in Chicago, Ill. As a world leader in circadian biology and endocrinology, his creativity and insights as an endocrinologist...
Almost three years ago, Kotaro Sasaki, MD, PhD, was lauded as one of the Endocrine Society’s Early Investigator Award winners. Now he discusses his research that involves building a human adrenal gland from stem cells, the importance for scientists to attend ENDO, and why the process of publishing research can often prove challenging. What if...
People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than those on a low-fat diet, according to a small study published in the Journal of the Endocrine Society. Type 2 diabetes is a disease where the beta cells in the pancreas cannot secrete enough insulin...
As my presidential term winds down, I look back with pride and admiration at the sheer amount of exemplary programming that the Society provides for its members each year. I’d like to recount some highlights from the past 12 months as we prepare to change leadership at ENDO 2026, June 13-16, in Chicago, Ill. One...
Endocrine Society member Joseph T. Bass, MD, PhD, has been elected to the American Academy of Arts & Sciences (AAAS). Bass is the Charles F. Kettering Professor of Medicine at Northwestern University Feinberg School of Medicine in Chicago, Ill. As a world leader in circadian biology and endocrinology, his creativity and insights as an endocrinologist...
